SNOMED CT Managed Service - Ireland Extension PRODUCTION Release Notes - October 2022
Date | 20221021 |
Document Version | 1.0 |
Release Status | PRODUCTION |
Introduction
SNOMED CT terminology provides a common language that enables a consistent way of indexing, storing, retrieving, and aggregating clinical data across specialties and sites of care.
The International Health Terminology Standards Development organisation (IHTSDO®), trading as SNOMED International, maintains the SNOMED CT technical design, the content architecture, the SNOMED CT content (includes the concepts table, the descriptions table, the relationships table, a history table, and ICD mappings), and related technical documentation.
The SNOMED CT Irish Extension - packages these components for release every April and October, to be used with the latest SNOMED CT International Edition release.
The same content can be viewed online using the SNOMED CT browser, and eHealth Ireland website
Background
This document provides a summarized description of the content changes included in the October 2022 Production release of the SNOMED Clinical Terms® Managed Service Ireland Extension package.
It will also include technical notes detailing the known issues which have been identified (should any of these exist). These are content or technical issues where the root cause is understood, and the fix has been discussed and agreed, but has yet to be implemented.
This Ireland Extension package is dependent upon, and should therefore be consumed in conjunction with the SNOMED CT® July 2022 International Edition release.
Scope
This document is written for the purpose described above and is not intended to provide details of the technical specifications for SNOMED CT or encompass every change made during the release.
Content Development Activity
Summary
Content from the SNOMED CT® July 2022 International Edition release has been included, alongside additional components for use in Ireland.
This extension contains concepts, relationships and reference sets for healthcare professionals.
New and Updated Content
New content in this release:
This is the 8th SNOMED CT Irish Edition Production release.
File | Changes |
Concept | 129 records added/updated, plus 0 records inactivated |
Description (EN) | 323 records added/updated, plus 0 records inactivated |
Language (EN) | 6999 records added/updated, plus 3649 records inactivated |
OWLExpression | 129 records added/updated, plus 0 records inactivated |
Inferred Relationship | 454 new records added/updated, plus 3 records inactivated |
Inferred Relationship Concrete Values | 0 records added/inactivated/updated |
RefsetDescriptor | 3 new records added/updated |
ModuleDependency | 3 records added, 2 existing records updated for new effectiveTime |
AttributeValue | 0 records added/updated, plus 0 records inactivated |
New and updated content
Concept statistics
File | Changes |
Concept | 129 |
Description (EN) | 323 |
Language (EN) | 6999 |
Inferred Relationship | 454 |
The SNOMED Irish National Release Centre published
Table 1.1 New concepts in the Irish Edition October release
Total number of concepts | 35 |
Assessment scales | 1 |
Disorder | 13 |
Finding | 24 |
Foundation metadata concept | 1 |
Medicinal Product | 5 |
Observable entity | 0 |
Procedure | 54 |
Record artifact | 2 |
Regime/therapy | 2 |
Situation | 6 |
Substance | 3 |
Ethnic group | 3 |
Medicinal Product | 5 |
Morphological abnormality | 4 |
Physical object | 19 |
Table 1.2
Relationships |
|
|---|---|
Total active relationships | 226 |
Inactivation's | 0 |
Total active descriptions | 226 |
Refer to Appendix 1, Table 1.2 to view the new relationships
This content was derived through the Dataset Specification Process (DSMP) and includes concepts from the following datasets
Table 1.3
Reference sets
File | Changes |
Association Refset | 0 new records added/updated, |
Adult oncology daycare nursing discharge SimpleRefset | 107 new records added for this brand new refset |
Epilepsy Simple Refset | 8 new records added for this brand new refset |
Breastcheck screening service SimpleRefset | 726 new records added for this brand new refset |
Nursing Midwifery Quality Care Metrics Dataset SimpleRefset | 194 records added/updated, plus 0 record inactivated |
Dentistry SimpleRefset | 119 records added/updated, plus 2 record inactivated |
National Ambulance Service SimpleRefset | 860 records added/updated, plus 0 record inactivated |
Patient Flow SimpleRefset | 91 records added/updated, plus 0 record inactivated |
Antimicrobial SimpleRefset | 2 records added/updated, plus 1 record inactivated |
Chronic Disease Management SimpleRefset | 2 records added/updated, plus 1 record inactivated |
eServices SimpleRefset | 1 records added/updated, plus 1 record inactivated |
Gynaecology SimpleRefset | 1 records added/updated, plus 1 record inactivated |
Lymphodema SimpleRefset | 52 records added/updated, plus 1 record inactivated |
Make every contact count SimpleRefset | 1 records added/updated, plus 1 record inactivated |
Safeguarding SimpleRefset | 3 records added/updated, plus 2 record inactivated |
Public Health SimpleRefset | 0 records added/inactivated/updated |
Irish National Early Warning Score SimpleRefset | 0 records added/inactivated/updated |
Coronavirus Reference set Ireland SimpleRefset | 0 records added/inactivated/updated |
Table 1.4
Text Definitions
Text definitions (metadata) | 3 |
Table 1.5
Content Promoted through CRS from IPU and acute medicines management programme
April 2022 | 22 |
May 2022 | 13 |
June 2022 | 42 |
July 2022 | 52 |
August 2022: | 46 |
Product containing precisely clarithromycin (as clarithromycin lactobionate) 500 mg/ 1vial powder for concentrate solution for infusion | 29/03/2022 | Completed |
Product containing precisely dacarbazine (as dacarbazine citrate) 1000 mg powder for conventional release solution for infusion (clinical drug) | 29/03/2022 | Completed |
Product containing precisely dacarbazine (as dacarbazine citrate) 200 mg powder for solutoin for injection/infusion | 29/03/2022 | Completed |
Product containing precisely dacarbazine (as dacarbazine citrate) 500 mg powder for conventional release solution for infusion (clinical drug) | 29/03/2022 | Completed |
Product containing precisely daptomycin 500 mg powder for conventional release solution for injection/infusion (clinical drug) | 29/03/2022 | Completed |
Product containing precisely decitabine 50 mg/1 vial powder for concentrate for solution for infusion (clinical drug) | 29/03/2022 | Completed |
Product containing precisely dexrazoxane (as dexrazoxane hydrochloride) 500 mg/ 1 vial powder for concentrate for solution for infusion | 29/03/2022 | Completed |
Product containing precisely efmoroctocog alfa 1000 units/ 1 vial powder for solution for injection (clinical drug) | 29/03/2022 | Completed |
Product containing precisely efmoroctocog alfa 1500 units/ 1 vial powder for solution for injection (clinical drug) | 29/03/2022 | Completed |
Product containing precisely efmoroctocog alfa 2000 units/ 1 vial powder for solution for injection (clinical drug) | 29/03/2022 | Completed |
Product containing precisely efmoroctocog alfa 250 units/ 1 vial powder for solution for injection (clinical drug) | 29/03/2022 | Completed |
Product containing precisely efmoroctocog alfa 3000 units/ 1 vial powder for solution for injection (clinical drug) | 29/03/2022 | Completed |
Product containing precisely efmoroctocog alfa 500 units/ 1 vial powder for solution for injection (clinical drug) | 29/03/2022 | Completed |
Product containing precisely epoprostenol (as epoprostenol sodium) 0.5 mg/1 vial powder for conventional release solution for infusion | 29/03/2022 | Completed |
Product containing precisely epoprostenol (as epoprostenol sodium) 1.5 mg/1 vial powder for conventional release solution for infusion | 29/03/2022 | Completed |
Product containing precisely esomeprazole (as esomeprazole sodium) 40 mg/1 vial powder for conventional release solution for injection | 29/03/2022 | Completed |
Product containing precisely etanercept 10 mg/1 vial powder for conventional release solution for injection (clinical drug) | 29/03/2022 | Completed |
Product containing precisely flucloxacillin (as flucloxacillin sodium) 2000 mg/1 vial powder for solution in injection or infusion | 30/03/2022 | Completed |
Product containing precisely invermectin 10mg/1g conventional release cutaneous cream (clinical drug) | 04/05/2022 | Completed |
Product containing precisely alprostadil 3mg/1g conventional release cutaneous cream (clinical drug) | 04/05/2022 | Completed |
Product containing precisely dimeticone 21 mg/2.5 ml conventional release suspension for oral drops (clinical drug) | 05/05/2022 | Completed |
Product containing precisely buprenorphine 5 microgram/1 hour transdermal patch (clinical drug) | 09/06/2022 | Completed |
Product containing precisely nicotine 156 microgram/1 hour prolonged-release transdermal patch (clinical drug) | 09/06/2022 | Completed |
Product containing precisely rotigotine 42 microgram/1 hour prolonged-release transdermal patch (clinical drug) | 09/06/2022 | Completed |
Product containing precisely rotigotine 125 microgram/1 hour prolonged-release transdermal patch (clinical drug) | 09/06/2022 | Completed |
Product containing precisely buprenorphine 15 microgram/1 hour prolonged-release transdermal patch (clinical drug) | 09/06/2022 | Completed |
Product containing precisely diclofenac sodium 40mg/ 1 gram conventional release cutaneous spray solution (clinical drug) | 09/06/2022 | Completed |
Product containing precisely dried magnesium sulfate 38.5 % conventional release cutaneous paste (clinical drug) | 09/06/2022 | Completed |
Product containing precisely zinc undecylenate 10% conventional release cutaneous powder (clinical dug) | 09/06/2022 | Completed |
Product containing precisely thyrotropin alfa 0.9 mg powder for conventional release solution for injection (clinical drug) | 09/06/2022 | Completed |
Product containing precisely vancomycin (as vancomycin hydrochloride) 1 g/1 vial conventional release powder for solution for infusion | 09/06/2022 | Completed |
Product containing precisely vancomycin (as vancomycin hydrochloride) 500mg/1 vial conventional release powder for solution for infusion | 09/06/2022 | Completed |
Product containing precisely verteporfin 15 mg/1 vial powder for conventional release solution for infusion (clinical drug) | 09/06/2022 | Completed |
Product containing precisely voriconazole 200 mg/1 vial powder for conventional release solution for infusion (clinical drug) | 09/06/2022 | Completed |
Product containing precisely clindamycin (as clindamycin phosphate) 20 mg/1 g conventional release vaginal cream | 04/07/2022 | Completed |
Product containing precisely dinoprostone 10 mg/1 each vaginal delivery system (clinical drug) | 04/07/2022 | Completed |
Product containing precisely estradiol (as estradiol hemihydrate) 10 mcg/1 each conventional release vaginal tablet (clinical drug) | 04/07/2022 | Completed |
Product containing precisely levonorgestrel 13.5 mg/1 each intrauterine delivery system(clinical drug) | 04/07/2022 | Completed |
Product containing precisely levonorgestrel 19.5 mg/1 vaginal delivery system (clinical drug) | 04/07/2022 | Completed |
Product containing precisely amikacin (as amikacin sulfate) 250mg/1ml solution for injection or infusion | 04/07/2022 | Completed |
Product containing precisely amikacin (as amikacin sulfate) 5 mg/1 ml conventional release solution for infusion | 04/07/2022 | Completed |
Product containing precisely brolucizumab 120 mg/1 ml conventional release solution for injection (clinical drug) | 04/07/2022 | Completed |